Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8875 |
High Similarity |
NPD3817 |
Phase 2 |
0.878 |
High Similarity |
NPD6232 |
Discontinued |
0.8735 |
High Similarity |
NPD7473 |
Discontinued |
0.8696 |
High Similarity |
NPD2801 |
Approved |
0.8647 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8634 |
High Similarity |
NPD1934 |
Approved |
0.8589 |
High Similarity |
NPD3882 |
Suspended |
0.858 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8563 |
High Similarity |
NPD6166 |
Phase 2 |
0.8563 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8563 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8491 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8462 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8424 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8421 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8412 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8397 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8372 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8365 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8364 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8363 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8324 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8313 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8313 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8313 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8293 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8282 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8256 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8242 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8242 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8199 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8198 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8193 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8155 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.8146 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.8137 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8133 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8103 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8079 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.8061 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8056 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8013 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.8 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7989 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7988 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7988 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7975 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7964 |
Intermediate Similarity |
NPD37 |
Approved |
0.7953 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7941 |
Intermediate Similarity |
NPD919 |
Approved |
0.7929 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7929 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7929 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7901 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7866 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7862 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.784 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7833 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7829 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7798 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7765 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7764 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7764 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7759 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7758 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7753 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7746 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7735 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.773 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7727 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7716 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7702 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7701 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7701 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7679 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7674 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7673 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7665 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7657 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7654 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7644 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7632 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7625 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7619 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7614 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.761 |
Intermediate Similarity |
NPD943 |
Approved |
0.761 |
Intermediate Similarity |
NPD1240 |
Approved |
0.76 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7593 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7566 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7566 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7566 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7566 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7566 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7566 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7566 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7561 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7531 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7515 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7515 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7514 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7485 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7473 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7473 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7456 |
Intermediate Similarity |
NPD920 |
Approved |
0.7439 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7436 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7423 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7421 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7407 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7405 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7398 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7398 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7382 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7381 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7381 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7375 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7363 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7358 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7358 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7358 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7356 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7349 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7337 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7337 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.732 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.732 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7316 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7308 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7308 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7302 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7302 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7296 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7284 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7284 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7273 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7263 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7246 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7231 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7231 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7219 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7212 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7206 |
Intermediate Similarity |
NPD7907 |
Approved |
0.7202 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7198 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7188 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7188 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7186 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7186 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7186 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7178 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.716 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7151 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7151 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7128 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7127 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7118 |
Intermediate Similarity |
NPD3300 |
Phase 2 |
0.7111 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7108 |
Intermediate Similarity |
NPD4111 |
Phase 1 |
0.7108 |
Intermediate Similarity |
NPD4665 |
Approved |
0.7108 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7086 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7086 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7081 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7077 |
Intermediate Similarity |
NPD2494 |
Approved |
0.7077 |
Intermediate Similarity |
NPD2493 |
Approved |
0.7069 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7069 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7066 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7066 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7066 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7066 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7062 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7055 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7053 |
Intermediate Similarity |
NPD5619 |
Clinical (unspecified phase) |
0.7051 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7044 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7043 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7041 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7039 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7037 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7035 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7033 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.703 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.703 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.703 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7025 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7024 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7012 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7005 |
Intermediate Similarity |
NPD7680 |
Approved |
0.699 |
Remote Similarity |
NPD3450 |
Approved |
0.699 |
Remote Similarity |
NPD3452 |
Approved |
0.6987 |
Remote Similarity |
NPD9545 |
Approved |
0.6981 |
Remote Similarity |
NPD9717 |
Approved |
0.697
|
Remote Similarity |
NPD4583 |
Approved |